Yuanming He

424 total citations
16 papers, 290 citations indexed

About

Yuanming He is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Yuanming He has authored 16 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Hematology. Recurrent topics in Yuanming He's work include Ubiquitin and proteasome pathways (9 papers), Protein Degradation and Inhibitors (4 papers) and Histone Deacetylase Inhibitors Research (3 papers). Yuanming He is often cited by papers focused on Ubiquitin and proteasome pathways (9 papers), Protein Degradation and Inhibitors (4 papers) and Histone Deacetylase Inhibitors Research (3 papers). Yuanming He collaborates with scholars based in China, Canada and Singapore. Yuanming He's co-authors include Xinliang Mao, Biyin Cao, Shuoyi Jiang, Zubin Zhang, Yuanying Zeng, Jun Zhao, Xiumin Zhou, Yuening Sun, Xiaofeng Xu and Peng Lin and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Letters and Cell Death and Disease.

In The Last Decade

Yuanming He

13 papers receiving 287 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yuanming He China	9	246	89	43	41	39	16	290
Gopichand Pendurti United States	6	133 0.5×	98 1.1×	76 1.8×	48 1.2×	52 1.3×	11	287
Isabel Weinhäuser Brazil	5	110 0.4×	49 0.6×	62 1.4×	49 1.2×	43 1.1×	19	217
Matthew D. Witkin United States	6	286 1.2×	81 0.9×	47 1.1×	43 1.0×	109 2.8×	8	365
Debra C. Ferguson United States	8	239 1.0×	94 1.1×	38 0.9×	16 0.4×	22 0.6×	14	341
Ruonan Shao China	9	186 0.8×	89 1.0×	51 1.2×	97 2.4×	53 1.4×	26	296
Marty J. Heslin United States	5	245 1.0×	104 1.2×	18 0.4×	51 1.2×	37 0.9×	7	329
Aaron M. Domina United States	6	353 1.4×	143 1.6×	64 1.5×	51 1.2×	54 1.4×	9	429
Jingrong Xian China	11	183 0.7×	42 0.5×	29 0.7×	77 1.9×	79 2.0×	13	261
Ling Sun China	11	201 0.8×	68 0.8×	61 1.4×	118 2.9×	81 2.1×	19	338
Yuanjue Sun China	7	295 1.2×	128 1.4×	22 0.5×	54 1.3×	31 0.8×	8	381

Countries citing papers authored by Yuanming He

Since Specialization

Citations

This map shows the geographic impact of Yuanming He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanming He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanming He more than expected).

Fields of papers citing papers by Yuanming He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanming He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanming He. The network helps show where Yuanming He may publish in the future.

Co-authorship network of co-authors of Yuanming He

This figure shows the co-authorship network connecting the top 25 collaborators of Yuanming He. A scholar is included among the top collaborators of Yuanming He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanming He. Yuanming He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Zhang, Lihuan, et al.. (2025). Inhibition of the PI3K/AKT signaling pathway blocks the oncogenic activity of TRIM26 in prostate cancer cells. Asian Journal of Andrology. 28(1). 89–95.

Liu, Ziyang, et al.. (2024). Inhibiting the Otub1/phosphorylated STAT3 axis for the treatment of non-small cell lung cancer. Acta Pharmacologica Sinica. 46(1). 184–195. 3 indexed citations

He, Yuanming, Shuoyi Jiang, Yao‐Li Cui, et al.. (2024). Induction of IFIT1/IFIT3 and inhibition of Bcl-2 orchestrate the treatment of myeloma and leukemia via pyroptosis. Cancer Letters. 588. 216797–216797. 7 indexed citations

He, Yuanming, et al.. (2023). Proteasomal inhibitors induce myeloma cell pyroptosis via the BAX/GSDME pathway. Acta Pharmacologica Sinica. 44(7). 1464–1474. 16 indexed citations

Zhang, Zubin, Mei Li, Peng Lin, et al.. (2023). The ubiquitin ligase HERC4 suppresses MafA transcriptional activity triggered by GSK3β in myeloma by atypical K63-linked polyubiquitination. Journal of Biological Chemistry. 299(5). 104675–104675. 1 indexed citations

Zhang, Hongxia, Yuanming He, Yujia Xu, et al.. (2023). RNF6 promotes chronic myelogenous leukemia cell proliferation and migration by stabilizing vimentin via multiple atypical ubiquitinations. Genes & Diseases. 11(1). 87–90.

He, Yuanming, Shuoyi Jiang, Xiaoge Wang, et al.. (2023). USP7 promotes non‐small‐cell lung cancer cell glycolysis and survival by stabilizing and activating c‐Abl. Clinical and Translational Medicine. 13(12). e1509–e1509. 19 indexed citations

Sun, Yuening, Peng Lin, Xiumin Zhou, et al.. (2023). TRIM26 promotes non-small cell lung cancer survival by inducing PBX1 degradation. International Journal of Biological Sciences. 19(9). 2803–2816. 18 indexed citations

He, Yuanming, Xiumin Zhou, Shuoyi Jiang, et al.. (2021). TRIM25 activates AKT/mTOR by inhibiting PTEN via K63-linked polyubiquitination in non-small cell lung cancer. Acta Pharmacologica Sinica. 43(3). 681–691. 41 indexed citations

10.

He, Yuanming, Shuoyi Jiang, Chenyu Mao, et al.. (2021). The deubiquitinase USP10 restores PTEN activity and inhibits non–small cell lung cancer cell proliferation. Journal of Biological Chemistry. 297(3). 101088–101088. 54 indexed citations

11.

Jiang, Shuoyi, Xiaoge Wang, Yuanming He, et al.. (2021). Suppression of USP7 induces BCR-ABL degradation and chronic myelogenous leukemia cell apoptosis. Cell Death and Disease. 12(5). 456–456. 26 indexed citations

12.

Liu, Yan, Xiaofeng Xu, Peng Lin, et al.. (2019). Inhibition of the deubiquitinase USP9x induces pre-B cell homeobox 1 (PBX1) degradation and thereby stimulates prostate cancer cell apoptosis. Journal of Biological Chemistry. 294(12). 4572–4582. 46 indexed citations

13.

He, Yuanming, Siyu Wang, Jiefei Tong, et al.. (2019). The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival. Journal of Biological Chemistry. 295(7). 2084–2096. 36 indexed citations

14.

Liu, Yan, et al.. (2018). Comparison of Chondrogenic Ability between Mesenchymal Stem Cells and Buffy Coat <i>in Vitro</i>. Journal of Biosciences and Medicines. 6(3). 86–94.

15.

Lu, Qin, Yuanming He, Yue‐Hu Wang, et al.. (2018). Saponins From Paris forrestii (Takht.) H. Li Display Potent Activity Against Acute Myeloid Leukemia by Suppressing the RNF6/AKT/mTOR Signaling Pathway. Frontiers in Pharmacology. 9. 673–673. 17 indexed citations

16.

Lin, Peng, Yuanming He, Guodong Chen, et al.. (2018). A novel hedgehog inhibitor for the treatment of hematological malignancies. Anti-Cancer Drugs. 29(10). 995–1003. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact